ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Effects of Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's Disease

ClinicalTrials.gov ID: NCT00219284

Public ClinicalTrials.gov record NCT00219284. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 10, 2026, 5:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Multi-center, Randomized, Open-label Study With Blinded Raters to Evaluate the Effects of Immediate Versus Delayed Switch to Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's Disease With End-of-dose Wearing Off

Study identification

NCT ID
NCT00219284
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
359 participants

Conditions and interventions

Interventions

  • Carbidopa/levodopa/entacapone Drug

Drug

Eligibility (public fields only)

Age range
30 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2004
Primary completion
Jun 30, 2008
Completion
Jun 30, 2008
Last update posted
Mar 29, 2017

2005 – 2008

United States locations

U.S. sites
41
U.S. states
20
U.S. cities
41
Facility City State ZIP Site status
Not listed Phoenix Arizona 85006
Not listed Fullerton California 92835
Not listed Irvine California 92618
Not listed La Jolla California 92037
Not listed Los Angeles California 90033
Not listed Pasadena California 91105
Not listed Reseda California 91355
Not listed Stanford California 94305
Not listed Fort Collins Colorado 80524
Not listed Washington D.C. District of Columbia 20007
Not listed Boca Raton Florida 33486
Not listed Bradenton Florida 34205
Not listed Fort Lauderdale Florida 33308
Not listed Hollywood Florida 33021
Not listed Naples Florida 34102
Not listed Palm Beach Florida 33418
Not listed Plantation Florida 33324
Not listed Pompano Beach Florida 33060
Not listed Port Charlotte Florida 33952
Not listed Chicago Illinois 60637
Not listed Flossmoor Illinois 60402
Not listed Lenexa Kansas 66214
Not listed Topeka Kansas 66606
Not listed Baltimore Maryland 21201
Not listed Bingham Farms Michigan 48025
Not listed Southfield Michigan 48034
Not listed Hattiesburg Mississippi 39401
Not listed Columbia Missouri 65201
Not listed St Louis Missouri 63141
Not listed Ridgewood New Jersey 07450
Not listed Commack New York 11725
Not listed Durham North Carolina 27705
Not listed Raleigh North Carolina 27607
Not listed Bellevue Ohio 44811
Not listed Canton Ohio 44718
Not listed Tualatin Oregon 97602
Not listed East Stroudsburg Pennsylvania 18301
Not listed Houston Texas 77030
Not listed Spokane Washington 99204
Not listed Tacoma Washington 98405
Not listed Milwaukee Wisconsin 53233

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00219284, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 29, 2017 · Synced May 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00219284 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →